Latest Tuberculosis treatment Stories
Researchers at Weill Cornell Medical College have found that an off-patent anti-inflammatory drug that costs about two cents for a daily dose can also kill both replicating and non-replicating drug-resistant tuberculosis in the laboratory.
Researchers from Queen Mary University of London have found that the “sunshine” vitamin can also aid in a speedy recovery from tuberculosis (TB).
Global NGO's Program to Improve Health of Ukrainians Through TB Testing And Other Measures to Prevent Rapid Increase of the Disease in Ukraine - Fifth Largest TB Burden Country In the World.
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two weeks and could be more effective than existing treatments.
In January, 2012, the U.S. Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB) because of a potential interaction between two of the main drugs used to treat each disease.
Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could — paradoxically — shorten treatment time for the highly contagious lung infection.
Immune Network Ltd. (IMMFF), announces the completion of a Phase II trial of a once-daily M. vaccae pill (V7) conducted by Immunitor in Ukraine.
- The abrogation of a law by a higher authority; annulment.